LABORATORIO REIG JOFRE, S.A. «12345...» Page 5 out of 20 28/02/2023 15:19 LABORATORIO REIG JOFRE, S.A. On corporate governance Reig Jofre informs on the resignation of the company REIG JOFRE INVESTMENTS, S.L. as a member of the Board of Directors Register number: 20948 28/02/2023 15:10 LABORATORIO REIG JOFRE, S.A. Announcement of general shareholders’ meeting Convening of the Ordinary General Shareholders’ Meeting of 2023 Register number: 20947 Notification modified by communication number 20980 dated 28/02/2023 (17:41) 28/02/2023 09:02 LABORATORIO REIG JOFRE, S.A. On business and financial situation Reig Jofre presents the results for the fourth quarter of 2022 Register number: 20902 28/02/2023 08:34 LABORATORIO REIG JOFRE, S.A. On business and financial situation Reig Jofre submits press release on the results of the fourth quarter of 2022 Register number: 20893 11/01/2023 17:03 LABORATORIO REIG JOFRE, S.A. Liquidity and counterparty agreements Reig Jofre informs on the a liquidity contract signed Register number: 19969 02/11/2022 09:07 LABORATORIO REIG JOFRE, S.A. Other relevant information Reig Jofre submits press release on the global license agreement reached by REIG JOFRE’s joint-venture, Syna Therapeutics Register number: 18968 31/10/2022 15:26 LABORATORIO REIG JOFRE, S.A. Share buy-back , stabilisation and treasury stock programmes Reig Jofre reports the acquisition within the Temporary Share Buy-back Program. Register number: 18961 28/10/2022 07:37 LABORATORIO REIG JOFRE, S.A. On business and financial situation Press release on the third quarter 2022 results Register number: 18923 28/10/2022 07:35 LABORATORIO REIG JOFRE, S.A. On business and financial situation Reig Jofre releases the third quarter 2022 Results Register number: 18922 26/10/2022 10:27 LABORATORIO REIG JOFRE, S.A. On business and financial situation The Company announces the release date of its Q3 2022 results Register number: 18848 Page 5 out of 20 «12345...»